Not all impactful consultancy projects require weeks of engagement. SeerPharma UK recently conducted a high-velocity, two-hour targeted consultation to provide a client with immediate clarity on the regulatory requirements for supplying medicinal products to the marine industry.

The Challenge

The client faced a complex intersection of pharmaceutical regulations and maritime law. Specifically, they needed to navigate the nuances of “Introduced Medicinal Products” and the licensing requirements for unlicensed medicines within a nautical context—a niche area where traditional distribution rules often collide with specialized maritime shipping notices.

The Solution

By leveraging our deep understanding of the Maritime and Coastguard Agency (MCA) shipping notices and current MHRA expectations, we provided rapid, expert-led advice. The session focused on:

• Niche Compliance: Deciphering the complexities of supplying medicines for use on vessels, ensuring all licensing hurdles were identified.
• Regulatory Interpretation: Clarifying the specific status of “Introduced Medicinal Products” to prevent potential legal or logistical bottlenecks.
• Up-to-the-Minute Intelligence: Applying the latest changes in marine sector legislation to ensure the client’s response to regulatory inquiries was both accurate and robust.

The Outcome

In just two hours, the client transitioned from regulatory uncertainty to a position of informed confidence. This case highlights SeerPharma UK’s ability to deliver “trustworthy advice on demand,” proving that even brief interventions can provide the critical insight needed to resolve complex pharmaceutical supply chain questions.

More case studies